Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments

Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments

Purpose: RANKL expression in the tumor microenvironment has been identified as a biomarker of immune suppression, negating the effect of some cancer immunotherapies. Previously we had developed a radiotracer based on the FDA-approved RANKL-specific antibody denosumab, [<sup>89</sup>Zr]Zr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonatan Dewulf, Ivanna Hrynchak, Sarah Geudens, Isabel Pintelon, Christel Vangestel, José Sereno, Peter A. van Dam, Antero J. Abrunhosa, Filipe Elvas, Tim Van den Wyngaert
Formato: Artículo
Lenguaje:English
Publicado: MDPI AG 2022-04-01
Colección:Pharmaceutics
Materias:
RANKL
antibody
Fab fragment
tumor imaging
immuno-PET
Acceso en línea:https://www.mdpi.com/1999-4923/14/5/939

Internet

https://www.mdpi.com/1999-4923/14/5/939

Ejemplares similares